Anlage C

Impfstoffe gemäß § 2 Abs. 1 Z 1

COVISHIELD/ChAdOx1_nCoV-19/COVID-19 Vaccine (ChAdOx1-S [recombinant]) von Serum Institute of India Pvt. Ltd.

Sinopharm/COVID-19 vaccine BIBP/BBIBP-CorV/BIBP (Beijing Institute of Biological Products Co-Ltd.) SARS-CoV-2 Vaccine (Vero Cell), Inactivated (InCoV) von Beijing Institute of Biological Products Co., Ltd. (BIBP)

Sinovac/CoronaVac/COVID-19 Vaccine (Vero Cell), Inactivated von Sinovac Life Sciences Co., Ltd.

COVAXIN/BBV152/SARS-CoV-2 Vaccine, Inactivated (Vero Cell)/ Covid-19 vaccine (Whole Virion Inactivated Corona Virus vaccine) von Bharat Biotech International Ltd.

COVOVAX/NVX-CoV2373/COVID-19 vaccine (SARS-CoV-2 rS Protein Nanoparticle [Recombinant]) von Serum Institute of India Pvt. Ltd.

CONVIDECIA/CanSinoBIO Ad5-nCoV-S/COVID-19 Vaccine (Ad5-nCoV-S [Recombinant]) von CanSino Biologics Inc.: 1 Dosis

Zuletzt aktualisiert am

09.01.2023

Gesetzesnummer

20011903

Dokumentnummer

NOR40250469